The March 2026 systematic review found oral doxycycline works about as well as azithromycin for acne vulgaris, the common condition with clogged pores, pimples, and inflamed lesions. The findings may not change care yet for adults with persistent acne because current guidelines still support doxycycline combinations and the review had small samples, short follow-up, and tolerability limits. Persistent acne in adults mainly affects women age 25 and older, either continuing from the teen years or starting later. For these readers, the practical question is not whether doxycycline works, but when its benefits outweigh sun sensitivity, stomach upset, and other options.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 2026 review actually tested
- How doxycycline compared on clearing
- Why side effects matter more in adult life
- What to do if you have persistent adult acne
What the 2026 review actually tested
The review evaluated oral doxycycline against other therapies for acne vulgaris using randomized controlled trials selected with PRISMA guidance, according to PubMed/NIH records published March 17, 2026. It pooled trials rather than reporting one new patient experiment.
The authors concluded doxycycline remains effective but called for more high-quality randomized trials, citing small samples, short follow-up, and open-label bias, as summarized in the NIH abstract. That design means the result is a comparative snapshot, not a new treatment standard.
How doxycycline compared on clearing
Treatment success was comparable between doxycycline and azithromycin, with an odds ratio of 1.28, 95% CI 0.54-3.04, p=0.57 and moderate heterogeneity. Inflammatory lesion-count reduction also did not differ significantly, with a mean difference of -0.71, 95% CI -8.61 to 7.19, p=0.86, according to the NIH full text.
Scores on the Global Acne Grading System favored control treatments over doxycycline by 1.76 points, 95% CI 1.53-2.00, p<0.00001. In a three-study subset, azithromycin led by 1.81 points. The pattern suggests similar clearing for many patients, without showing doxycycline as stronger.
Why side effects matter more in adult life
Doxycycline caused more gastrointestinal and skin adverse events than azithromycin in the trials. One trial reported 12% versus 4% gastrointestinal events, another reported 46% versus 20%, with a pooled gastrointestinal risk ratio of 0.43 favoring azithromycin.
That difference matters for workdays, makeup use, outdoor time, and consistent pill-taking. Adult female acne has an estimated prevalence of 12-54% and often involves hormonal drivers, so a treatment that irritates the stomach or skin can quickly disrupt routine use.
What to do if you have persistent adult acne
Current American Academy of Dermatology 2024 guidance still strongly recommends oral doxycycline with benzoyl peroxide, retinoids, and combination regimens, as reported by Medical Dialogues in its guideline summary. Comparable efficacy alone does not replace that combination approach.
Ask a clinician whether a doxycycline combination still fits your lesion type, prior antibiotics, pregnancy plans, sun exposure, and stomach tolerance. Prescribing information warns about sun sensitivity requiring sun minimization, stomach upset, and Clostridioides difficile-associated diarrhea that requires stopping the drug if it occurs. Bring photos of flares, a list of topicals tried, and notes on missed doses due to side effects.
You Might Also Like
- Topical Hormonal Acne Treatments in a 2026 Review: What Researchers Still Need to Learn for Adults With Persistent Acne
- The 2026 Systematic Review of Acne and Quality of Life: What the Findings Mean for Young Adults With Acne
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: What the Research Means for Adults With Persistent Acne